Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
In Re: Zetia (Ezetimibe) Antitrust Litigation
Case Number:
2:18-md-02836
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Berger Montague
- BoiesBattin
- Boies Schiller
- Cohen Milstein
- Crenshaw Ware
- Crowell & Moring
- DLA Piper
- Duncan & Allen
- Durrette Arkema
- DurretteCrump
- Faruqi & Faruqi
- Fisher & Phillips
- Furniss Davis
- Garwin Gerstein
- Gibson Dunn
- Girard Sharp
- Glancy Prongay
- Glasser & Glasser
- Goldman Ismail
- Grabar Law
- Gustafson Gluek
- Hagens Berman
- Hangley Aronchick
- Hartley LLP
- Heins Mills
- Hilliard & Shadowen
- Joseph Saveri Law Firm
- Katten Muchin
- Kaufman & Canoles
- Kenny Nachwalter
- Kessler Topaz
- Kirkland & Ellis
- Labaton Keller
- Lockridge Grindal
- Marcus & Shapira
- McDermott Will & Emery
- McGuireWoods
- Miller Shah LLP
- Morgan Lewis
- Motley Rice
- Nussbaum Law Group
- O'Hagan Meyer
- Radice Law Firm
- Smith Segura
- Sperling & Slater
- Taus Cebulash
- The Office of Craig C. Reilly
- Vanek Vickers
- Ventker Henderson
- Wexler Boley
- White & Case
- Willcox & Savage
- Williams & Connolly
- Wilson Sonsini
- Winston & Strawn
- Wolcott Rivers
- Woods Rogers
- Zelle LLP
Companies
- Albertsons Cos. Inc.
- Cardinal Health Inc.
- Cencora Inc.
- Centene Corp.
- CVS Health Corp.
- Fraternal Order of Police
- Giant Eagle Inc.
- Glenmark Pharmaceuticals Ltd.
- H.D. Smith LLC
- Health Net Inc.
- H‑E‑B LP
- Humana Inc.
- J.M. Smith Corp.
- McKesson Corp.
- Merck & Co. Inc.
- Mutual Drug
- Par Pharmaceutical Cos. Inc.
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Supervalu Inc.
- The Kroger Co.
- United Food & Commercial Workers International Union
- Wegmans Food Markets Inc.
- WellCare Health Plans Inc.
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
-
August 24, 2020
Zetia Buyers Granted Cert. Despite Small Class Size
A Virginia federal judge granted class certification Friday to Zetia direct buyers accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of the cholesterol drug off the market, rejecting attacks on the small size of the class and the companies representing them.
-
August 17, 2020
Zetia Buyers Win Recommendation For Class Cert.
A federal magistrate judge has recommended that a group of Zetia buyers be granted class certification in a dispute accusing Merck and Glenmark Pharmaceuticals of conspiring to keep a generic version of the cholesterol drug off the market.
-
July 07, 2020
Merck, Glenmark Implore Court To Reject Zetia Class Cert.
Merck and Glenmark Pharmaceuticals are trying to convince a Virginia federal court to smack down a magistrate's recommendation to certify a class of direct purchasers who have accused the duo of conspiring to keep a generic version of the cholesterol drug Zetia off the market.
-
May 06, 2020
Zetia Buyers Blast Merck's 'Unhinged' Bid To Eject Class Rep
A proposed class of drug buyers is coming out swinging after the second of two "desperate efforts" to unseat its lead plaintiff in a suit accusing Merck and Glenmark Pharmaceuticals of teaming up to keep a generic version of the cholesterol drug Zetia off the market.
-
March 09, 2020
Judge OKs Par's Settlement In Zetia Pay-For-Delay Case
A Virginia federal judge has given the final greenlight to a settlement that knocks Par Pharmaceutical out of a massive suit accusing Merck and Glenmark of plotting to hold off generic versions of Zetia and inflating the cholesterol drug's costs.
-
December 23, 2019
Zetia Buyers' Lose Antitrust Claims Against Merck, Glenmark
Drug wholesalers and retailers alleging Merck, Glenmark and Par Pharmaceuticals were part of a conspiracy to keep generic versions of cholesterol drug Zetia off the market can't sue Merck and Glenmark for overcharges they purportedly paid for Glenmark's generic, a Virginia federal judge ruled.
-
November 19, 2019
Direct Buyers Seek Cert. In Zetia Generic Delay Suit
Direct drug buyers accusing Merck and Glenmark of conspiring to keep a generic version of the cholesterol drug Zetia off the market have urged a Virginia federal judge to certify their class, saying the alleged conspiracy forced the class members to pay higher prices.
-
October 30, 2019
Zetia Generic Delay Was A Conspiracy, Court Told
A Virginia federal judge was wrong to recommend that drugmakers Merck and Glenmark be cleared of allegations that they were part of a three-way conspiracy to keep a generic version of the cholesterol drug Zetia off the market, direct drug buyers said Tuesday.
-
October 29, 2019
Retailers Fight To Keep 3-Way Zetia Conspiracy Claim In MDL
Kroger, Walgreens and a host of other retailers urged a Virginia federal judge Tuesday not to take up a magistrate's recommendation to clear Merck and Glenmark of allegations that they were part of a three-way conspiracy to keep a generic version of the cholesterol drug Zetia off the market.
-
October 16, 2019
Toss 3-Way Zetia Conspiracy Claim, Judge Says
A group of direct purchaser plaintiffs may find it harder to prove a pay-for-delay scheme over a generic version of Merck's Zetia after a Virginia federal judge recommended Tuesday that the drugmaker and generics company Glenmark be cleared of allegations of a three-way conspiracy with Glenmark's distributor, Par Pharmaceuticals.